tiprankstipranks
Trending News
More News >
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC

Cyclacel Pharmaceuticals (CYCC) Revenue

Compare
732 Followers

Cyclacel Pharmaceuticals Revenue

Cyclacel Pharmaceuticals had a revenue of 0.00 in the quarter ending Mar 31, 2025, with 100.00%. This bring the company's revenue in the last twelve months to -21.00K, Increased -362.50%. In the fiscal year ending Dec 31, 2024, Cyclacel Pharmaceuticals had annual revenue of 43.00K with -89.76% growth.
Revenue (ttm)
-21.00K
Revenue Growth
-89.76%
P/S Ratio
163.47
Revenue/Employee
$3,583
Employees
12
Market Cap
$7.03M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
43.00K-377.00K-89.76%
Dec 31, 2023
420.00K+∞%
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00-150.00K-100.00%
Dec 31, 2018
150.00K+∞%
Dec 31, 2017
0.00-843.00K-100.00%
Dec 31, 2016
843.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis